Hilltop Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.86M Buy
4,177
+542
+15% +$241K 0.12% 200
2025
Q1
$1.76M Buy
3,635
+90
+3% +$43.6K 0.11% 197
2024
Q4
$1.43M Buy
3,545
+402
+13% +$162K 0.09% 240
2024
Q3
$1.46M Buy
3,143
+2,459
+360% +$1.14M 0.09% 230
2024
Q2
$321K Hold
684
0.04% 458
2024
Q1
$286K Buy
684
+2
+0.3% +$836 0.03% 512
2023
Q4
$277K Sell
682
-10
-1% -$4.07K 0.03% 485
2023
Q3
$241K Sell
692
-11
-2% -$3.83K 0.03% 498
2023
Q2
$247K Sell
703
-7
-1% -$2.46K 0.03% 477
2023
Q1
$224K Sell
710
-2
-0.3% -$630 0.03% 474
2022
Q4
$206K Hold
712
0.03% 484
2022
Q3
$206K Buy
+712
New +$206K 0.03% 467
2021
Q2
Sell
-1,509
Closed -$324K 591
2021
Q1
$324K Buy
+1,509
New +$324K 0.04% 386
2020
Q3
Sell
-757
Closed -$220K 452
2020
Q2
$220K Buy
+757
New +$220K 0.04% 351
2018
Q4
Sell
-1,534
Closed -$296K 420
2018
Q3
$296K Buy
+1,534
New +$296K 0.06% 317